6. Goldstein, J. L., Hobbs, H. H., Brown, M. S. In The Metabolic and Molecular Basis of In herited Disease, ed. Scriber CR. pp.1981-2030, New York, McGraw-Hill, 7th ed., 1995.
9. Parthasarathy, S., Young, S. G., Witztum, J. L., Pittman, R. C., Steinberg, D. Probucol in hibits oxidative modification of low density lipoprotein. J. Clin. Invest. 77:641-644.
10. O'Brien K, Nagano Y, Gown A, Kita T, Chait A. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe Heritable Hyperlipidemic Rabbits. Arterioscler Thromb 11:751-759, 1991.
11. Kodama T, Freeman M, Rohrer L et al. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature 343:531-535, 1990.
20. Raines, E. W., Rosenfeld, M. E, Ross, R. The role of macrophages. In : Fuster, V., Ross, R., Topol, E. J. eds. Atherosclerosis and coronary artery disease. Vol. 1. pp. 539-555. Lippencott-Raven, Philadelphia. 1996.
21. Hansson, G. K., Libby, P. The role of the lymphocyte. In : Fuster, V., Ross, R., Topol, E. J. eds. Atherosclerosis and coronary artery disease. Vol.1. pp.557-568. Lippencott-Raven, Philadelphia. 1996.
23. Murayama, T., Yokode, M., Kataoka, H., Imabayashi, T., Yoshida, H., Sano, H., Nishikawa, S., Nishikawa, S-1., Kita, T. In traperitoneal Administration of Anti-c-fms Monoclonal Antibody Prevents the Initial Events of Atherogenesis but Does Not Reduce the Size of Advanced Lesions in Apolipoprotein E-Deficient Mice. Circulation. 99:1740-1746. 1999.
24. Meier. C. R., Derby, L. E., Jick, S. S., Vasilakis, C., Jick, H. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA ; 281:427-431, 1999.
31. Mach, F, Schonbeck, U., Sukhova, G. K., Atkinson, E., Libby, P. Reduction of athero sclerosis in mice by inhibition of CD40 signalling. Nature 394:200-203, 1998.